Antimalarial medications from native remedy

Central-European Journal of Immunology

Volumn 36, Issue 2, 2011, Pages 100-103

  Kalotka KRȨGLEWSKA, Hanna ^a  

^a Gabinet Lekarski MEDIKA   (Poland)

Author keywords

Antimalarials; Autoimmune diseases; Quinine

Indexed keywords

ARTEMETHER; ATOVAQUONE; BENFLUMETOL; CHLOROQUINE; CINCHONA ALKALOID; CLINDAMYCIN; DIHYDROARTEMISININ; DOXYCYCLINE; HYDROXYCHLOROQUINE; MEFLOQUINE; PIPERAQUINE; PRIMAQUINE; PROGUANIL; PYRIMETHAMINE; QUININE;

ANTIMALARIAL ACTIVITY; AUTOIMMUNE DISEASE; DRUG EFFICACY; HUMAN; MALARIA; NONHUMAN; PLASMODIUM FALCIPARUM; PLASMODIUM MALARIAE; PLASMODIUM OVALE; PLASMODIUM VIVAX; RETINOPATHY; REVIEW; THROMBOCYTE AGGREGATION; THROMBOCYTE AGGREGATION INHIBITION;

EID: 79959394909     PISSN: 14263912     EISSN: 16444124     Source Type: Journal    
DOI: None     Document Type: Review

References (23)

1. Reveal JL (1999): System of Classification. In: PBIO 250 Lecture Notes: Plant Taxonomy. Department of Plant Biology, University of Maryland.
2. Motley C (2010): "Cinchona and its product-Quinine". Ethnobotanical leaflets. Southern Illinois University Herbarium.
3. Woodward R, Doering W (1944): The Total Synthesis of Quinine. J Am Chem Soc 66: 849.
4. Druilhe P, Brandicourt O, Chongsuphajaisiddhi T, Berthe J (1988): Activity of a combination of three cinchona bark alkaloids against Plasmodium falciparum in vitro. Antimicrob Agents Chemother 32: 250-254. (Pubitemid 18061384)
5. Hempelmann E (2007): Hemozoin biocrystallization in Plasmodium falciparum and the anti-malarial activity of crystallization inhibitors. Parasitol Res 100: 671-676.
6. Cowman AF (1995): Mechanisms of drug resistance in malaria. Aust N Z J Med 25: 837-844.
7. Wofsy D (2005): Therapy of systemic lupus erythematosus. In: Koopman WJ, Moreland LW (eds.). Arthritis and Allied Conditions: A Textbook of Rheumatology. 15th ed., vol. 2, Lippincott Williams and Wilkins, Philadelphia: 1561-1574.
8. Tassiulas LO (2008): Clinical Features and Treatment of Systemic Lupus Erythematosus. In: Firestein GS et al. Kelley's Textbook of Rheumatology. 8th ed., W.B. Saunders Elsevier, Philadelphia.
9. Hughes G (2000): Lupus: The Facts. Oxford University Press, New York: 36-40.
10. Aletaha D, Neogi T, Silman AJ et al. (2010): Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Ann Rheum Dis 69: 1580-1588.
11. Kuhn A, Ochsendorf F, Bonsmann G (2010): Treatment of cutaneous lupus erythematosus. Lupus 19: 1125-1136.
12. Cankaya H, Alpöz E, Karabulut G et al. (2010): Effects of hydroxychloroquine on salivary flow rates and oral complaints of Sjögren patients: a prospective sample study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 110: 62-67.
13. Katz SJ, Russell AS (2011): Re-evaluation of antimalarials in treating rheumatic diseases: re-appreciation and insights into new mechanisms of action. Curr Opin Rheumatol 23: 278-281.
14. Kuznik A, Bencina M, Svajger U et al. (2011): Mechanism of endosomal TLR inhibition by antimalarial drugs and imidazoquinolines. J Immunol 186: 4794-4804.
15. Cutler DJ (1993): Possible mechanisms of action of antimalarials in rheumatic disease. Agents Actions Suppl 44: 139-143.
16. Adler HS, Steinbrink K (2007): Tolerogenic dendritic cells in health and disease: friend and foe! Eur J Dermatol 17: 476-491. (Pubitemid 350207158)
17. Cankaya H, Alpöz E, Karabulut G et al. (2010): Effects of hydroxychloroquine on salivary flow rates and oral complaints of Sjögren patients: a prospective sample study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 110: 62-67.
18. Smolen JS, Landewé R, Breedveld FC et al. (2010): EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs. Ann Rheum Dis 69: 964-975.
19. Rantalaiho V, Korpela M, Laasonen L et al. (2010): Early combination disease-modifying antirheumatic drug therapy and tight disease control improve long-term radiologic outcome in patients with early rheumatoid arthritis: the 11-year results of the Finnish Rheumatoid Arthritis Combination Therapy trial. Arthritis Res Ther 12: R122.
20. Michaelides M, Stover NB, Francis PJ, Weleber RG (2011): Retinal toxicity associated with hydroxychloroquine and chloroquine: risk factors, screening, and progression despite cessation of therapy. Arch Ophthalmol 129: 30-39.
21. Kobak S, Deveci H (2010): Retinopathy due to antimalarial drugs in patients with connective tissue diseases: are they so innocent? Asingle center retrospective study. Int J Rheum Dis 13: e11-15.
22. Bernatsky S, Pineau C, Joseph L, Clarke A(2003): Adherence to ophthalmologic monitoring for antimalarial toxicity in a lupus cohort. J Rheumatol 30: 1756-1760. (Pubitemid 36962452)
23. Taylor WR, White NJ (2004): Antimalarial drug toxicity: a review. Drug Saf 27: 25-61. (Pubitemid 38186936)